top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
Novartis’ Fabhalta Demonstrates Improved Hemoglobin Levels in PNH Patients Switching from Anti-C5 Therapy | iPharmaCenter
Novartis has announced positive results from the Phase IIIB APPULSE-PNH study, highlighting the effectiveness of Fabhalta (iptacopan), an...
Hypertension | News | Updates | iPharmaCenter
Janssen Pharmaceutical has updated the Phase 3 MACiTEPH study, which evaluates macitentan 75mg in patients with Chronic Thromboembolic...
Coronary Artery Disease | News | Blogs | Updates
Bayer presented the long-term studies of Xarelto in patients with coronary artery disease and/or peripheral artery disease. Bayer has...
bottom of page